BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 16 filers reported holding BIOANALYTICAL SYS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | – | 83 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 83 | -6.7% | 0.00% | – |
| Q1 2019 | $0 | – | 89 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 89 | +1383.3% | 0.00% | – |
| Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 760,015 | $9,348,000 | 9.78% |
| Versant Capital Management, Inc | 19,191 | $236,000 | 0.09% |
| NEXT CENTURY GROWTH INVESTORS LLC | 43,458 | $534,000 | 0.04% |
| EAM Investors, LLC | 21,958 | $270,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 67,510 | $830,000 | 0.02% |
| Virtu Financial LLC | 10,089 | $124,000 | 0.01% |
| Renaissance Technologies | 600,065 | $7,381,000 | 0.01% |
| Private Advisor Group, LLC | 64,500 | $793,000 | 0.01% |
| VANGUARD GROUP INC | 147,163 | $1,810,000 | 0.00% |
| UBS Group AG | 1,324 | $16,000 | 0.00% |